Tg Therapeutics (TGTX) Capital Expenditures (2012 - 2026)
Tg Therapeutics (TGTX) recorded quarterly Capital Expenditures of $51000.0 in Q1 2026, down 23.88% quarter-over-quarter from $67000.0 in Q4 2025, and up 104.0% on a YoY basis from $25000.0 in Q1 2025.
Tg Therapeutics (TGTX) Capital Expenditures (2012 - 2026) Analysis & Trends
Tg Therapeutics' Capital Expenditures history runs 14 years deep, the most recent figure standing at $51000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 104.0% year-over-year to $51000.0; the TTM figure through Mar 2026 stood at $240000.0 (up 242.86% YoY), while the FY2025 annual figure was $214000.0, up 375.56% from the prior year.
- Capital Expenditures was $51000.0 for Q1 2026 at Tg Therapeutics, down from $67000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $80000.0 in Q3 2025 to a low of $3000.0 in Q4 2022.
- Historically, Capital Expenditures has averaged $32400.0 across 4 years, with a median of $24500.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures sank 96.25% in 2022, then soared 233.33% in 2025.
- A 4-year view of Capital Expenditures shows it stood at $3000.0 in 2022, then soared by 600.0% to $21000.0 in 2024, then surged by 219.05% to $67000.0 in 2025, then decreased by 23.88% to $51000.0 in 2026.
- The last three Capital Expenditures figures came in at $51000.0 (Q1 2026), $67000.0 (Q4 2025), and $80000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn | 51,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Mar 31, 2022 | 7,000.00 |